Peripheral metabotropic glutamate receptors differentially modulate mustard oil-induced craniofacial muscle pain in lightly anesthetized rats

  • Lee, Min-K. (Department of Oral Physiology and Institution of BrainKorea21, School of Dentistry, Kyungpook National University) ;
  • Yang, Gwi-Y. (Department of Oral Physiology and Institution of BrainKorea21, School of Dentistry, Kyungpook National University) ;
  • Ahn, Dong-K. (Department of Oral Physiology and Institution of BrainKorea21, School of Dentistry, Kyungpook National University)
  • 발행 : 2008.09.30

초록

The present study investigated the role of peripheral group I, II, and III metabotropic glutamate receptors (mGluRs) in mustard oil (MO)-induced nociceptive response in the masseter muscles of lightly anesthetized rats. Experiments were carried out on male Sprague-Dawley rats weighing 300-350 gm. After initial anesthesia with sodium pentobarbital (40 mg/kg, i.p.), one femoral vein was cannulated and connected to an infusion pump for intravenous infusion of sodium pentobarbital. The rate of infusion was adjusted to provide a constant level of anesthesia. MO (30 ${\mu}L$) was injected into the mid-region of the left masseter muscle via a 30-gauge needle over 10 seconds. After 30 mL injection of 5, 10, 15, or 20% MO into the masseter muscle, total number of hindpaw-shaking behavior was monitored. Intramuscular administration of MO significantly produced hindpawshaking behavior in a dose-dependent manner, as compared with the vehicle (mineral oil)-treated group. Intramuscular pretreatment with 10 or 100 ng DHPG, a group I mGluRs agonist, enhanced MO-induced hindpaw-shaking behavior, while APDC (20 or 200 ${\mu}g$), a group II mGluRs agonist, or L-AP4 (2 ${\mu}g$), a group III mGluRs agonist, significantly reduced MO-induced nociceptive behavior. The antinociception, produced by group II or III mGluRs agonists, was abolished by pretreatment with LY341495, a group II mGluRs antagonist, or CPPG, a group III mGluRs antagonist, res-pectively. Based on these observations, peripheral mGluRs differentially modulated MO-induced nociceptive behavior response in the craniofacial muscle pain and peripheral group II and III mGluRs agonists could be used in treatment of craniofacial muscle nociception.

키워드

참고문헌

  1. Ahn DK, Kim KH, Jung CY, Choi HS, Lim EJ, Youn DH, Bae YC. Role of peripheral group I and II metabotropic glutamate receptors in IL-1b-induced mechanical allodynia in the orofacial area of conscious rats. Pain 2005;118:53-60 https://doi.org/10.1016/j.pain.2005.07.017
  2. Battaglia G, Monn JA, Schoepp DD. In vivo inhibition of veratridine-evoked release of striatal excitatory amino acids by the group II metabotropic glutamate receptor agonist LY354740 in rats. Neurosci Lett. 1997;229:161-4 https://doi.org/10.1016/S0304-3940(97)00442-4
  3. Bhave G, Karim F, Carlton SM, Gereau IV RW. Peripheral group I metabotropic glutamate receptors modulate nociception in mice. Nat Neurosci. 2001;4:417-23 https://doi.org/10.1038/86075
  4. Carlton SM, Hargett GL, Coggeshall RE. Localization of metabotropic glutamate receptors 2/3 on primary afferent axons in the rat. Neuroscience 2001;105:957-69 https://doi.org/10.1016/S0306-4522(01)00238-X
  5. Chen SR, Pan HL. Distinct roles of group III metabotropic glutamate receptors in control of nociception and dorsal horn neurons in normal and nerve-injured rats. J Pharmacol Exp Ther. 2005;312:120-6
  6. Clements JR, Magnusson KR, Hurtman J, Beitz AJ. Rat tooth pulp projections to spinal trigeminal subnucleus caudalis are glutamate-like immunoreactivity. J Com Neurol. 1991;309:281-8 https://doi.org/10.1002/cne.903090209
  7. Conn PJ, Pin JP. Pharmacology and functions of metabotropic glutamate receptors. Ann Rev Pharmacol Toxicol. 1997;37:205-37 https://doi.org/10.1146/annurev.pharmtox.37.1.205
  8. Cozzi A, Attucci S, Peruginelli F, Marinozzi M, Luneia R, Pellicciari R, Moroni F. Type 2 metabotropic glutamate (mGlu) receptors tonically inhibit transmitter release in rat caudate nucleus: in vivo studies with (2S,1'S,2'S,3'R)-2-(2'- carboxy-3'-phenylcyclopropyl)glycine, a new potent and selective antagonist. Eur J Neurosci . 1997;9:1350-5 https://doi.org/10.1111/j.1460-9568.1997.tb01489.x
  9. Dolan S, Nolan AM. Behavioral evidence supporting a differential role for group I and II metabotropic glutamate receptors in spinal nociceptive transmission. Neuropharmacology 2000;39:1132-8 https://doi.org/10.1016/S0028-3908(99)00200-2
  10. East SJ, Hill MP, Brotchie JM. Metabotropic glutamate receptor agonists inhibit endogenous glutamate release from rat striatal synaptosomes. Eur J Pharmacol. 1995;277:117-21 https://doi.org/10.1016/0014-2999(95)00119-6
  11. Fisher K, Coderre TJ. The contribution of metabotropic glutamate receptors (mGluRs) to formalin-induced nociception. Pain 1996;68:255-63 https://doi.org/10.1016/S0304-3959(96)03212-5
  12. Fisher K, Lefebvre C, Coderre, TJ. Antinociceptive effects following intrathecal pretreatment with selective metabotropic glutamate receptor compounds in a rat model of neuropathic pain. Pharmacol Biochem Behav. 2002;73:411-8 https://doi.org/10.1016/S0091-3057(02)00832-8
  13. Gereau IV RW, Conn PJ. Multiple presynaptic metabotropic glutamate receptors modulate excitatory and inhibitory synaptic transmission in hippocampal area CA1. J Neurosci. 1995;15:6879-89 https://doi.org/10.1523/JNEUROSCI.15-10-06879.1995
  14. Jia H, Rustioni A, Valtschanoff JG. Metabotropic glutamate receptors in superficial laminae of the rat dorsal horn. J Comp Neurol. 1999;410:627-42 https://doi.org/10.1002/(SICI)1096-9861(19990809)410:4<627::AID-CNE9>3.0.CO;2-8
  15. Kehl LJ, Trempe TM, Hargreaves KM. A new animal model for assessing mechanisms and management of muscle hyperalgesia. Pain 2000;85:333-43 https://doi.org/10.1016/S0304-3959(99)00282-1
  16. Kellgren JH. Observations on referred pain arising from muscle. Clin Sci. 1938;3:175-90
  17. Lee HJ, Choi HS, Ju JS, Bae YC, Kim SK, Yoon YW, Ahn DK. Peropheral mGluR5 antagonist attenuated craniofacial muscle pain and inflammation but not mGluR1 antagonist in lightly anesthetized rats. Brain Res Bull. 2006;70:378-85 https://doi.org/10.1016/j.brainresbull.2005.09.021
  18. Loram LC, Fuller A, Fick FG, Cartmell T, Poole S, Mitchell D. Cytokine Profiles During Carrageenan-Induced Inflammatory Hyperalgesia in Rat Muscle and Hind Paw. J Pain 2007;8(2):127-36 https://doi.org/10.1016/j.jpain.2006.06.010
  19. Lujan R, Nusser Z, Roberts JD, Shigemoto R, Somogyi P. Perisynaptic location of metabotropic glutamate receptors mGluR1 and mGluR5 on dendrites and dendritic spines in the rat hippocampus. Eur J Neurosci. 1996;8:1488-500 https://doi.org/10.1111/j.1460-9568.1996.tb01611.x
  20. Macek TA, Winder DG, Gereau IV RW, Ladd CO, Conn PJ. Differential involvement of group II and group III mGluRs as autoreceptors at lateral and medial perforant path synapses. J Neurophysiol. 1996;76:3798-806 https://doi.org/10.1152/jn.1996.76.6.3798
  21. Neki A, Ohishi H, Kaneko T, Shigemoto R, Nakanishi S, Mizuno N. Pre- and postsynaptic localization of a metabotropic glutamate receptor, mGluR2, in the rat brain: an immunohistochemical study with a monoclonal antibody. Neurosci Lett. 1996;202:197-200 https://doi.org/10.1016/0304-3940(95)12248-6
  22. Neugebauer V, Chen PS, Willis WD. Groups II and III metabotropic glutamate receptors differentially modulate brief and prolonged nociception in primate STT cells. J Neurophysiol. 2000;84:2998-3009 https://doi.org/10.1152/jn.2000.84.6.2998
  23. Neugebauer V. Metabotropic glutamate receptors--important modulators of nociception and pain behavior. Pain 2002;98:1-8 https://doi.org/10.1016/S0304-3959(02)00140-9
  24. Ohishi H, Shigemoto R, Nakanishi S, Mizuno N. Distribution of the mRNA for a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat. Neuroscience 1993a;53: 1009-18 https://doi.org/10.1016/0306-4522(93)90485-X
  25. Ohishi H, Shigemoto R, Nakanishi S, Mizuno N. Distribution of the mRNA for a metabotropic glutamate receptor (mGluR3) in the rat brain: an in situ hybridization study. J Comp Neurol. 1993b;335:252-66 https://doi.org/10.1002/cne.903350209
  26. Pin JP, Duvoisin R. The metabotropic glutamate receptors: structure and functions. Neuropharmacology 1995;34:1-26 https://doi.org/10.1016/0028-3908(94)00129-G
  27. Ro JY, Capra N, Masri R. Development of a behavioral assessment of craniofacial muscle pain in lightly anesthetized rats. Pain 2003;104:179-85 https://doi.org/10.1016/S0304-3959(03)00005-8
  28. Ro JY. Bite force measurement in awake rats: a behavioral model for persistent orofacial muscle pain and hyperalgesia. J Orofac Pain 2005;19:159-67
  29. Schoepp DD, Conn PJ. Metabotropic glutamate receptors in brain function and pathology. Trensd Pharmacol Sci. 1993;14:13-20
  30. Schoepp DD, Jane DE, Monn JA. Pharmacologyical agents acting at subtypes of metabotropic glutamate receptors. Neuropharmacology 1999;38:1431-76 https://doi.org/10.1016/S0028-3908(99)00092-1
  31. Shigemoto R, Kinoshita A, Wada E, Nomura S, Ohishi H, Takada M, Flor PJ, Neki A, Abe T, Nakanishi S, Mizuno N. Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus. J Neurosci. 1997;17:7503-22 https://doi.org/10.1523/JNEUROSCI.17-19-07503.1997
  32. Simmons RM, Webster AA, Kalra AB, Iyengar S. Group II mGluR receptor agonists are effective in persistent and neuropathic pain models in rats. Pharmacol Biochem Behav. 2002;73:419-27 https://doi.org/10.1016/S0091-3057(02)00849-3
  33. Sluka KA. Stimulation of deep somatic tissue with capsaicin produces long-lasting mechanical allodynia and heat hypoalgesia that depends on early activation of the cAMP pathway. J Neurosci. 2002;22:5687-93 https://doi.org/10.1523/JNEUROSCI.22-13-05687.2002
  34. Tallaksen-Greene SJ, Young AB, Penney JB, Beitz AJ. Excitatory amino acid binding sites in the trigeminal principal sensory and spinal trigeminal nuclei of the rat. Neurosci Lett. 1992;141:79-83 https://doi.org/10.1016/0304-3940(92)90339-9
  35. Taylor DL, Diemel LT, Pocock JM. Activation of microglial group III metabotropic glutamate receptors protects neurons against microglial neurotoxicity. J Neurosci. 2003;23:2150- 60 https://doi.org/10.1523/JNEUROSCI.23-06-02150.2003
  36. Vignes M, Clarke VR, Davies CH, Chambers A, Jane DE, Watkins JC, Collingridge GL. Pharmacological evidence for an involvement of group II and group III mGluRs in the presynaptic regulation of excitatory synaptic responses in the CA1 region of rat hippocampal slices. Neuropharmacology 1995;34:973-82 https://doi.org/10.1016/0028-3908(95)00093-L
  37. Walker K, Bowes M, Panesar M, Davis A, Gentry C, Kesingland A, Gasparini F, Spooren W, Stoehr N, Pagano A, Flor PJ, Vranesic I, Lingenhoehl K, Johnson EC, Varney M, Urban L, Kuhn R. Metabotropic glutamate receptor subtype 5 (mGluR5) and nociceptive function. I. Selective blockade of mGluR5 receptors in model of acute, persistent and chronic pain. Neuropharmacology 2001a;40:1-9 https://doi.org/10.1016/S0028-3908(00)00113-1
  38. Walker K, Reeve A, Bowes M, Winter J, Wotherspoon G, Davis A, Schmid P, Gasparini F, Kuhn R, Urban L. mGluR5 receptors and nociceptive function II. mGluR5 receptors functionally expressed on peripheral sensory neurons mediate inflammatory hyperalgesia. Neuropharmacology 2001b;40:10-19 https://doi.org/10.1016/S0028-3908(00)00114-3
  39. Watkins JC, Evans RH. Excitatory amino acid transmitters. Annu Rev Pharmacol Toxicol. 1981;21:165-20 https://doi.org/10.1146/annurev.pa.21.040181.001121